Some aspects of the pathogenesis of prostatic hyperplasia.
D000324:Adrenocorticotropic Hormone / Q000096:biosynthesis; D000818:Animals; D003687:Dehydroepiandrosterone / Q000378:metabolism; D013196:Dihydrotestosterone / Q000096:biosynthesis / Q000502:physiology; D004967:Estrogens / Q000494:pharmacology / Q000502:physiology*; D005260:Female; D005916:Globulins / Q000378:metabolism; D006801:Humans; D008297:Male; D051379:Mice; D010902:Pituitary Gland / Q000033:anatomy & histology / Q000187:drug effects; D011247:Pregnancy; D011374:Progesterone / Q000378:metabolism; D011388:Prolactin / Q000096:biosynthesis / Q000378:metabolism; D011467:Prostate / Q000033:anatomy & histology / Q000187:drug effects / Q000378:metabolism; D011470:Prostatic Hyperplasia / Q000209:etiology* / Q000378:metabolism; D051381:Rats; D011956:Receptors, Cell Surface; D013268:Stimulation, Chemical; D013739:Testosterone / Q000502:physiology*; D014316:Tritium
D004967:Estrogens; D005916:Globulins; D011956:Receptors, Cell Surface; D013196:Dihydrotestosterone; D014316:Tritium; D013739:Testosterone; D003687:Dehydroepiandrosterone; D011374:Progesterone; D000324:Adrenocorticotropic Hormone; D011388:Prolactin